{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:02:37Z","timestamp":1790676157665,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":2293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/modpathol.2016.101","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T07:45:26Z","timestamp":1469173526000},"page":"1254-1261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Elisabetta","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Doberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asli","family":"Bahadirli-Talbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Smith","family":"Sehdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Kurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2016.101_bib1","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/modpathol.2016.101_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The dualistic model of ovarian carcinogenesis. revisited, revised and expanded","volume":"186","author":"Kurman","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2016.101_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1038\/modpathol.2016.101_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1038\/modpathol.2016.101_bib5","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.101_bib6","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1097\/PAS.0b013e31825ec07a","article-title":"The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma","volume":"36","author":"Kuhn","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.101_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","article-title":"Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas","volume":"123","author":"Karst","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2016.101_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2015.07.100","article-title":"Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma","volume":"139","author":"Novak","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2016.101_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.101_bib10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.101_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PAS.0000000000000352","article-title":"Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series","volume":"39","author":"Morrison","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.101_bib12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAS.0000000000000353","article-title":"Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas","volume":"39","author":"Gilks","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.101_bib13","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/IGC.0b013e3181a1b5dc","article-title":"High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy","volume":"19","author":"Hirst","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2016.101_bib14","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000000199","article-title":"Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery","volume":"38","author":"Rabban","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.101_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2016.101_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma- evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2016.101_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2016.101_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","article-title":"A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development","volume":"233","author":"Sherman-Baust","year":"2014","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2016.101_bib19","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1158\/1078-0432.CCR-14-3368","article-title":"Mevalonate pathway antagonist inhibits proliferation of serous tubal intraepithelial carcinoma and ovarian carcinoma in mouse models","volume":"21","author":"Kobayashi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2016.101_bib20","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/jamaoncol.2015.1618","article-title":"Next-generation sequencing of tubal intraepithelial carcinomas","volume":"1","author":"McDaniel","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1038\/modpathol.2016.101_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2004.12.028","article-title":"Centrosome amplification, chromosome instability and cancer development","volume":"230","author":"Fukasawa","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1038\/modpathol.2016.101_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.101_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole-genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.101_bib24","doi-asserted-by":"crossref","first-page":"e15498","DOI":"10.1371\/journal.pone.0015498","article-title":"Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer","volume":"5","author":"Etemadmoghadam","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/modpathol.2016.101_bib25","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/ijc.22609","article-title":"Amplicon profiles in ovarian serous carcinomas","volume":"120","author":"Nakayama","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2016.101_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/modpathol.2010.60","article-title":"Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase","volume":"23","author":"Sehdev","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.101_bib27","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/0008-5472.CAN-13-2247","article-title":"Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers","volume":"74","author":"Karst","year":"2014","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.101_bib28","first-page":"1235","article-title":"Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a Gynecologic Oncology Group study","volume":"63","author":"Farley","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.101_bib29","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cncr.21767","article-title":"Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma","volume":"106","author":"Rosen","year":"2006","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2016.101_bib30","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/cncr.22918","article-title":"Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma","volume":"110","author":"Davidson","year":"2007","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2016.101_bib31","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/ncb2345","article-title":"The centrosome cycle: centriole biogenesis, duplication and inherent asymmetries","volume":"13","author":"Nigg","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1038\/modpathol.2016.101_bib32","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.11.031","article-title":"High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome","volume":"128","author":"Cope","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1038\/modpathol.2016.101_bib33","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/modpathol.2013.209","article-title":"Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma","volume":"27","author":"Kuhn","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.101_bib34","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1016\/j.ejca.2013.08.011","article-title":"Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium","volume":"49","author":"Kuhn","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1038\/modpathol.2016.101_bib35","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/path.4147","article-title":"Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development","volume":"229","author":"Sheu","year":"2013","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2016.101_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/45836","article-title":"Deregulated cyclin E induces chromosome instability","volume":"401","author":"Spruck","year":"1999","journal-title":"Nature"},{"key":"10.1038\/modpathol.2016.101_bib37","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1158\/0008-5472.CAN-09-4094","article-title":"Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification","volume":"70","author":"Bagheri-Yarmand","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2016.101_bib38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/modpathol.2014.89","article-title":"Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma","volume":"28","author":"Chui","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2016.101_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10059-009-0017-z","article-title":"Ab ovo or de novo? Mechanisms of centriole duplication","volume":"27","author":"Loncarek","year":"2009","journal-title":"Mol Cells"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222015435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2016101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:50:27Z","timestamp":1760230227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222015435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0893395222015435"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2016.101","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCNE1 amplification and centrosome number abnormality in serous tubal intraepithelial carcinoma: further evidence supporting its role as a precursor of ovarian high-grade serous carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2016.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}